Randox Laboratories Ltd:医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C6418)
◆英語タイトル:Randox Laboratories Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6418
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers diagnostic, prognostic and predictive solutions for cardiovascular disease, infectious disease and cancer. Randox also provides testing services. Its products find application in various areas including hospital laboratories; clinical, research and molecular laboratories; forensic toxicology laboratories; food testing laboratories; and life sciences and veterinary laboratories. The company has its manufacturing and research and development (R&D) facilities in Ireland, India, the UK and the US. Randox is headquartered in Antrim, Northern Ireland, the UK.

Randox Laboratories Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Randox Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Randox Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Randox Laboratories Ltd, Medical Equipment, Deal Details 10
Partnerships 10
University of Surrey Enters Into Licensing Agreement With Randox For Engrailed-2 Biomarker 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 11
Aterovax Enters Into Licensing Agreement With Randox For sPLA2 Test 12
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 13
Randox Laboratories Ltd – Key Competitors 14
Randox Laboratories Ltd – Key Employees 15
Randox Laboratories Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Feb 22, 2018: £50m Randox Centres of Excellence launched in Northern Ireland 17
Product News 19
May 18, 2018: Neonatal health testing from Randox: what to expect after birth 19
Apr 16, 2018: Vivalytic: The all-in-one solution for Molecular Diagnostics 20
Mar 21, 2018: Biochip Carrier Applications in the Randox Evidence Series 21
Jan 06, 2017: Randox supports calls from Oxford University for more accurate diagnosis of diabetes following report warning 22
Other Significant Developments 23
May 02, 2018: Neonatal health testing from Randox: keeping your baby healthy now and into the future 23
Mar 28, 2018: Randox: Extreme Weather Results In High Risk Of Mycotoxin Contamination 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Randox Laboratories Ltd, Medical Equipment, Key Facts 2
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Randox Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Randox Laboratories Ltd, Deals By Market, 2012 to YTD 2018 8
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
University of Surrey Enters Into Licensing Agreement With Randox For Engrailed-2 Biomarker 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 11
Aterovax Enters Into Licensing Agreement With Randox For sPLA2 Test 12
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 13
Randox Laboratories Ltd, Key Competitors 14
Randox Laboratories Ltd, Key Employees 15
Randox Laboratories Ltd, Other Locations 16

List of Figures
Randox Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Randox Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Randox Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Randox Laboratories Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Randox Laboratories Ltd:医療機器:M&Aディール及び事業提携情報(Randox Laboratories Ltd - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆